APO Research, Inc.

APO RESEARCH · REPORT

Pyrazinamide

Selected research

Industry Research

Pyrazinamide Industry Research Report 2026

Market perspective

The global Pyrazinamide market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Pyrazinamide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Pyrazinamide is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Pyrazinamide is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Pyrazinamide include Beijing Ouhe Technology, Energy Chemical, Waterstone Technology, Toronto Research Chemicals, TCI, Pure Chemistry Scientific, Meryer (Shanghai) Chemical Technology, LGM Pharma and J & K SCIENTIFIC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Pyrazinamide market in terms of revenue (US$ million) and, where applicable, sales volume (W Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Tons) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Pyrazinamide Market by Company

Beijing Ouhe Technology

Energy Chemical

Waterstone Technology

Toronto Research Chemicals

TCI

Pure Chemistry Scientific

Meryer (Shanghai) Chemical Technology

LGM Pharma

J & K SCIENTIFIC

HBCChem

EDQM

City Chemical

AlliChem

Alfa Chemistry

Acros Organics

Pyrazinamide Segment by Type

Purity 98%

Purity 99%

Others

Pyrazinamide Segment by Application

Children

Adult

Pyrazinamide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pyrazinamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pyrazinamide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pyrazinamide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Pyrazinamide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Pyrazinamide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Pyrazinamide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pyrazinamide Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Pyrazinamide Sales (W Tons) of Manufacturers (2021-2026) Table 7. Global Pyrazinamide Sales Market Share by Manufacturers (2021-2026) Table 8. Global Pyrazinamide Revenue of Manufacturers (2021-2026) Table 9. Global Pyrazinamide Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Pyrazinamide Average Price (US$/Ton) of Manufacturers (2021-2026) Table 11. Global Pyrazinamide Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Pyrazinamide, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Pyrazinamide, Product Type & Application Table 14. Global Pyrazinamide Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Pyrazinamide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Beijing Ouhe Technology Company Information Table 19. Beijing Ouhe Technology Business Overview Table 20. Beijing Ouhe Technology Pyrazinamide Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 21. Beijing Ouhe Technology Pyrazinamide Product Portfolio Table 22. Beijing Ouhe Technology Recent Developments Table 23. Energy Chemical Company Information Table 24. Energy Chemical Business Overview Table 25. Energy Chemical Pyrazinamide Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 26. Energy Chemical Pyrazinamide Product Portfolio Table 27. Energy Chemical Recent Developments Table 28. Waterstone Technology Company Information Table 29. Waterstone Technology Business Overview Table 30. Waterstone Technology Pyrazinamide Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 31. Waterstone Technology Pyrazinamide Product Portfolio Table 32. Waterstone Technology Recent Developments Table 33. Toronto Research Chemicals Company Information Table 34. Toronto Research Chemicals Business Overview Table 35. Toronto Research Chemicals Pyrazinamide Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 36. Toronto Research Chemicals Pyrazinamide Product Portfolio Table 37. Toronto Research Chemicals Recent Developments Table 38. TCI Company Information Table 39. TCI Business Overview Table 40. TCI Pyrazinamide Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 41. TCI Pyrazinamide Product Portfolio Table 42. TCI Recent Developments Table 43. Pure Chemistry Scientific Company Information Table 44. Pure Chemistry Scientific Business Overview Table 45. Pure Chemistry Scientific Pyrazinamide Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 46. Pure Chemistry Scientific Pyrazinamide Product Portfolio Table 47. Pure Chemistry Scientific Recent Developments Table 48. Meryer (Shanghai) Chemical Technology Company Information Table 49. Meryer (Shanghai) Chemical Technology Business Overview Table 50. Meryer (Shanghai) Chemical Technology Pyrazinamide Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 51. Meryer (Shanghai) Chemical Technology Pyrazinamide Product Portfolio Table 52. Meryer (Shanghai) Chemical Technology Recent Developments Table 53. LGM Pharma Company Information Table 54. LGM Pharma Business Overview Table 55. LGM Pharma Pyrazinamide Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 56. LGM Pharma Pyrazinamide Product Portfolio Table 57. LGM Pharma Recent Developments Table 58. J & K SCIENTIFIC Company Information Table 59. J & K SCIENTIFIC Business Overview Table 60. J & K SCIENTIFIC Pyrazinamide Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 61. J & K SCIENTIFIC Pyrazinamide Product Portfolio Table 62. J & K SCIENTIFIC Recent Developments Table 63. HBCChem Company Information Table 64. HBCChem Business Overview Table 65. HBCChem Pyrazinamide Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. HBCChem Pyrazinamide Product Portfolio Table 67. HBCChem Recent Developments Table 68. EDQM Company Information Table 69. EDQM Business Overview Table 70. EDQM Pyrazinamide Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. EDQM Pyrazinamide Product Portfolio Table 72. EDQM Recent Developments Table 73. City Chemical Company Information Table 74. City Chemical Business Overview Table 75. City Chemical Pyrazinamide Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. City Chemical Pyrazinamide Product Portfolio Table 77. City Chemical Recent Developments Table 78. AlliChem Company Information Table 79. AlliChem Business Overview Table 80. AlliChem Pyrazinamide Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. AlliChem Pyrazinamide Product Portfolio Table 82. AlliChem Recent Developments Table 83. Alfa Chemistry Company Information Table 84. Alfa Chemistry Business Overview Table 85. Alfa Chemistry Pyrazinamide Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Alfa Chemistry Pyrazinamide Product Portfolio Table 87. Alfa Chemistry Recent Developments Table 88. Acros Organics Company Information Table 89. Acros Organics Business Overview Table 90. Acros Organics Pyrazinamide Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Acros Organics Pyrazinamide Product Portfolio Table 92. Acros Organics Recent Developments Table 93. Global Pyrazinamide Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 94. Global Pyrazinamide Sales by Region (2021-2026) & (W Tons) Table 95. Global Pyrazinamide Sales Market Share by Region (2021-2026) Table 96. Global Pyrazinamide Sales by Region (2027-2032) & (W Tons) Table 97. Global Pyrazinamide Sales Market Share by Region (2027-2032) Table 98. Global Pyrazinamide Revenue by Region (2021-2026) & (US$ Million) Table 99. Global Pyrazinamide Revenue Market Share by Region (2021-2026) Table 100. Global Pyrazinamide Revenue by Region (2027-2032) & (US$ Million) Table 101. Global Pyrazinamide Revenue Market Share by Region (2027-2032) Table 102. North America Pyrazinamide Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. North America Pyrazinamide Sales by Country (2021-2026) & (W Tons) Table 104. North America Pyrazinamide Sales by Country (2027-2032) & (W Tons) Table 105. North America Pyrazinamide Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Pyrazinamide Revenue by Country (2027-2032) & (US$ Million) Table 107. Europe Pyrazinamide Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Europe Pyrazinamide Sales by Country (2021-2026) & (W Tons) Table 109. Europe Pyrazinamide Sales by Country (2027-2032) & (W Tons) Table 110. Europe Pyrazinamide Revenue by Country (2021-2026) & (US$ Million) Table 111. Europe Pyrazinamide Revenue by Country (2027-2032) & (US$ Million) Table 112. Asia Pacific Pyrazinamide Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Asia Pacific Pyrazinamide Sales by Country (2021-2026) & (W Tons) Table 114. Asia Pacific Pyrazinamide Sales by Country (2027-2032) & (W Tons) Table 115. Asia Pacific Pyrazinamide Revenue by Country (2021-2026) & (US$ Million) Table 116. Asia Pacific Pyrazinamide Revenue by Country (2027-2032) & (US$ Million) Table 117. South America Pyrazinamide Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. South America Pyrazinamide Sales by Country (2021-2026) & (W Tons) Table 119. South America Pyrazinamide Sales by Country (2027-2032) & (W Tons) Table 120. South America Pyrazinamide Revenue by Country (2021-2026) & (US$ Million) Table 121. South America Pyrazinamide Revenue by Country (2027-2032) & (US$ Million) Table 122. Middle East and Africa Pyrazinamide Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Middle East and Africa Pyrazinamide Sales by Country (2021-2026) & (W Tons) Table 124. Middle East and Africa Pyrazinamide Sales by Country (2027-2032) & (W Tons) Table 125. Middle East and Africa Pyrazinamide Revenue by Country (2021-2026) & (US$ Million) Table 126. Middle East and Africa Pyrazinamide Revenue by Country (2027-2032) & (US$ Million) Table 127. Global Pyrazinamide Sales by Type (2021-2026) & (W Tons) Table 128. Global Pyrazinamide Sales by Type (2027-2032) & (W Tons) Table 129. Global Pyrazinamide Sales Market Share by Type (2021-2026) Table 130. Global Pyrazinamide Sales Market Share by Type (2027-2032) Table 131. Global Pyrazinamide Revenue by Type (2021-2026) & (US$ Million) Table 132. Global Pyrazinamide Revenue by Type (2027-2032) & (US$ Million) Table 133. Global Pyrazinamide Revenue Market Share by Type (2021-2026) Table 134. Global Pyrazinamide Revenue Market Share by Type (2027-2032) Table 135. Global Pyrazinamide Price by Type (2021-2026) & (US$/Ton) Table 136. Global Pyrazinamide Price by Type (2027-2032) & (US$/Ton) Table 137. Global Pyrazinamide Sales by Application (2021-2026) & (W Tons) Table 138. Global Pyrazinamide Sales by Application (2027-2032) & (W Tons) Table 139. Global Pyrazinamide Sales Market Share by Application (2021-2026) Table 140. Global Pyrazinamide Sales Market Share by Application (2027-2032) Table 141. Global Pyrazinamide Revenue by Application (2021-2026) & (US$ Million) Table 142. Global Pyrazinamide Revenue by Application (2027-2032) & (US$ Million) Table 143. Global Pyrazinamide Revenue Market Share by Application (2021-2026) Table 144. Global Pyrazinamide Revenue Market Share by Application (2027-2032) Table 145. Global Pyrazinamide Price by Application (2021-2026) & (US$/Ton) Table 146. Global Pyrazinamide Price by Application (2027-2032) & (US$/Ton) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Pyrazinamide Distributors List Table 150. Pyrazinamide Customers List Table 151. Pyrazinamide Industry Trends Table 152. Pyrazinamide Industry Drivers Table 153. Pyrazinamide Industry Restraints Table 154. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Pyrazinamide Product Image Figure 5. Global Pyrazinamide Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Pyrazinamide Market Size (2021-2032) & (US$ Million) Figure 7. Global Pyrazinamide Sales (2021-2032) & (W Tons) Figure 8. Global Pyrazinamide Average Price (US$/Ton) & (2021-2032) Figure 9. Purity 98% Product Image Figure 10. Purity 99% Product Image Figure 11. Others Product Image Figure 12. Children Product Image Figure 13. Adult Product Image Figure 14. Global Pyrazinamide Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Pyrazinamide, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Pyrazinamide Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Pyrazinamide Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Pyrazinamide Sales by Region in 2025 Figure 20. Global Pyrazinamide Revenue by Region in 2025 Figure 21. North America Pyrazinamide Market Size by Country in 2025 Figure 22. North America Pyrazinamide Sales Market Share by Country (2021-2032) Figure 23. North America Pyrazinamide Revenue Market Share by Country (2021-2032) Figure 24. United States Pyrazinamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Pyrazinamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Pyrazinamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Pyrazinamide Market Size by Country in 2025 Figure 28. Europe Pyrazinamide Sales Market Share by Country (2021-2032) Figure 29. Europe Pyrazinamide Revenue Market Share by Country (2021-2032) Figure 30. Germany Pyrazinamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Pyrazinamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Pyrazinamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Pyrazinamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Pyrazinamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Pyrazinamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Pyrazinamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Pyrazinamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Pyrazinamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Pyrazinamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Pyrazinamide Market Size by Country in 2025 Figure 41. Asia Pacific Pyrazinamide Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Pyrazinamide Revenue Market Share by Country (2021-2032) Figure 43. China Pyrazinamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Pyrazinamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Pyrazinamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Pyrazinamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Pyrazinamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Pyrazinamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Pyrazinamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Pyrazinamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Pyrazinamide Market Size by Country in 2025 Figure 52. South America Pyrazinamide Sales Market Share by Country (2021-2032) Figure 53. South America Pyrazinamide Revenue Market Share by Country (2021-2032) Figure 54. Brazil Pyrazinamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Pyrazinamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Pyrazinamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Pyrazinamide Market Size by Country in 2025 Figure 58. Middle East and Africa Pyrazinamide Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Pyrazinamide Revenue Market Share by Country (2021-2032) Figure 60. Egypt Pyrazinamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Pyrazinamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Pyrazinamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Pyrazinamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Pyrazinamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Pyrazinamide Sales Market Share by Type (2021-2032) Figure 66. Global Pyrazinamide Revenue Market Share by Type (2021-2032) Figure 67. Global Pyrazinamide Price (US$/Ton) by Type (2021-2032) Figure 68. Global Pyrazinamide Sales Market Share by Application (2021-2032) Figure 69. Global Pyrazinamide Revenue Market Share by Application (2021-2032) Figure 70. Global Pyrazinamide Price (US$/Ton) by Application (2021-2032) Figure 71. Pyrazinamide Value Chain Figure 72. Pyrazinamide Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Pyrazinamide Industry Opportunities and Challenges

Scope & coverage.

Types
  • Purity 98%
  • Purity 99%
  • Others
Applications
  • Children
  • Adult
Companies covered
  • Beijing Ouhe Technology
  • Energy Chemical
  • Waterstone Technology
  • Toronto Research Chemicals
  • TCI
  • Pure Chemistry Scientific
  • Meryer (Shanghai) Chemical Technology
  • LGM Pharma
  • J & K SCIENTIFIC
  • HBCChem
  • EDQM
  • City Chemical
  • AlliChem
  • Alfa Chemistry
  • Acros Organics

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Pyrazinamide Market Size (2021-2032)
  4. 2.2.2 Global Pyrazinamide Sales (2021-2032)
  5. 2.2.3 Global Pyrazinamide Market Average Price (2021-2032)
  6. 2.3 Pyrazinamide by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Purity 98%
  9. 2.3.3 Purity 99%
  10. 2.3.4 Others
  11. 2.4 Pyrazinamide by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Children
  14. 2.4.3 Adult
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Pyrazinamide Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Pyrazinamide Sales (W Tons) of Manufacturers (2021-2026)
  3. 3.3 Global Pyrazinamide Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Pyrazinamide Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Pyrazinamide Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Pyrazinamide, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Pyrazinamide, Product Type & Application
  8. 3.8 Global Manufacturers of Pyrazinamide, Established Date
  9. 3.9 Global Pyrazinamide Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Beijing Ouhe Technology
  2. 4.1.1 Beijing Ouhe Technology Company Information
  3. 4.1.2 Beijing Ouhe Technology Business Overview
  4. 4.1.3 Beijing Ouhe Technology Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Beijing Ouhe Technology Pyrazinamide Product Portfolio
  6. 4.1.5 Beijing Ouhe Technology Recent Developments
  7. 4.2 Energy Chemical
  8. 4.2.1 Energy Chemical Company Information
  9. 4.2.2 Energy Chemical Business Overview
  10. 4.2.3 Energy Chemical Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Energy Chemical Pyrazinamide Product Portfolio
  12. 4.2.5 Energy Chemical Recent Developments
  13. 4.3 Waterstone Technology
  14. 4.3.1 Waterstone Technology Company Information
  15. 4.3.2 Waterstone Technology Business Overview
  16. 4.3.3 Waterstone Technology Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Waterstone Technology Pyrazinamide Product Portfolio
  18. 4.3.5 Waterstone Technology Recent Developments
  19. 4.4 Toronto Research Chemicals
  20. 4.4.1 Toronto Research Chemicals Company Information
  21. 4.4.2 Toronto Research Chemicals Business Overview
  22. 4.4.3 Toronto Research Chemicals Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Toronto Research Chemicals Pyrazinamide Product Portfolio
  24. 4.4.5 Toronto Research Chemicals Recent Developments
  25. 4.5 TCI
  26. 4.5.1 TCI Company Information
  27. 4.5.2 TCI Business Overview
  28. 4.5.3 TCI Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 TCI Pyrazinamide Product Portfolio
  30. 4.5.5 TCI Recent Developments
  31. 4.6 Pure Chemistry Scientific
  32. 4.6.1 Pure Chemistry Scientific Company Information
  33. 4.6.2 Pure Chemistry Scientific Business Overview
  34. 4.6.3 Pure Chemistry Scientific Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Pure Chemistry Scientific Pyrazinamide Product Portfolio
  36. 4.6.5 Pure Chemistry Scientific Recent Developments
  37. 4.7 Meryer (Shanghai) Chemical Technology
  38. 4.7.1 Meryer (Shanghai) Chemical Technology Company Information
  39. 4.7.2 Meryer (Shanghai) Chemical Technology Business Overview
  40. 4.7.3 Meryer (Shanghai) Chemical Technology Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Meryer (Shanghai) Chemical Technology Pyrazinamide Product Portfolio
  42. 4.7.5 Meryer (Shanghai) Chemical Technology Recent Developments
  43. 4.8 LGM Pharma
  44. 4.8.1 LGM Pharma Company Information
  45. 4.8.2 LGM Pharma Business Overview
  46. 4.8.3 LGM Pharma Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 LGM Pharma Pyrazinamide Product Portfolio
  48. 4.8.5 LGM Pharma Recent Developments
  49. 4.9 J & K SCIENTIFIC
  50. 4.9.1 J & K SCIENTIFIC Company Information
  51. 4.9.2 J & K SCIENTIFIC Business Overview
  52. 4.9.3 J & K SCIENTIFIC Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 J & K SCIENTIFIC Pyrazinamide Product Portfolio
  54. 4.9.5 J & K SCIENTIFIC Recent Developments
  55. 4.10 HBCChem
  56. 4.10.1 HBCChem Company Information
  57. 4.10.2 HBCChem Business Overview
  58. 4.10.3 HBCChem Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 HBCChem Pyrazinamide Product Portfolio
  60. 4.10.5 HBCChem Recent Developments
  61. 4.11 EDQM
  62. 4.11.1 EDQM Company Information
  63. 4.11.2 EDQM Business Overview
  64. 4.11.3 EDQM Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 EDQM Pyrazinamide Product Portfolio
  66. 4.11.5 EDQM Recent Developments
  67. 4.12 City Chemical
  68. 4.12.1 City Chemical Company Information
  69. 4.12.2 City Chemical Business Overview
  70. 4.12.3 City Chemical Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 City Chemical Pyrazinamide Product Portfolio
  72. 4.12.5 City Chemical Recent Developments
  73. 4.13 AlliChem
  74. 4.13.1 AlliChem Company Information
  75. 4.13.2 AlliChem Business Overview
  76. 4.13.3 AlliChem Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 AlliChem Pyrazinamide Product Portfolio
  78. 4.13.5 AlliChem Recent Developments
  79. 4.14 Alfa Chemistry
  80. 4.14.1 Alfa Chemistry Company Information
  81. 4.14.2 Alfa Chemistry Business Overview
  82. 4.14.3 Alfa Chemistry Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Alfa Chemistry Pyrazinamide Product Portfolio
  84. 4.14.5 Alfa Chemistry Recent Developments
  85. 4.15 Acros Organics
  86. 4.15.1 Acros Organics Company Information
  87. 4.15.2 Acros Organics Business Overview
  88. 4.15.3 Acros Organics Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Acros Organics Pyrazinamide Product Portfolio
  90. 4.15.5 Acros Organics Recent Developments
5 Global Pyrazinamide Market Scenario by Region
  1. 5.1 Global Pyrazinamide Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Pyrazinamide Sales by Region: 2021-2032
  3. 5.2.1 Global Pyrazinamide Sales by Region: 2021-2026
  4. 5.2.2 Global Pyrazinamide Sales by Region: 2027-2032
  5. 5.3 Global Pyrazinamide Revenue by Region: 2021-2032
  6. 5.3.1 Global Pyrazinamide Revenue by Region: 2021-2026
  7. 5.3.2 Global Pyrazinamide Revenue by Region: 2027-2032
  8. 5.4 North America Pyrazinamide Market Facts & Figures by Country
  9. 5.4.1 North America Pyrazinamide Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Pyrazinamide Sales by Country (2021-2032)
  11. 5.4.3 North America Pyrazinamide Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Pyrazinamide Market Facts & Figures by Country
  16. 5.5.1 Europe Pyrazinamide Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Pyrazinamide Sales by Country (2021-2032)
  18. 5.5.3 Europe Pyrazinamide Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Pyrazinamide Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Pyrazinamide Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Pyrazinamide Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Pyrazinamide Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Pyrazinamide Market Facts & Figures by Country
  41. 5.7.1 South America Pyrazinamide Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Pyrazinamide Sales by Country (2021-2032)
  43. 5.7.3 South America Pyrazinamide Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Pyrazinamide Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Pyrazinamide Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Pyrazinamide Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Pyrazinamide Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Pyrazinamide Sales by Type (2021-2032)
  2. 6.1.1 Global Pyrazinamide Sales by Type (2021-2032) & (W Tons)
  3. 6.1.2 Global Pyrazinamide Sales Market Share by Type (2021-2032)
  4. 6.2 Global Pyrazinamide Revenue by Type (2021-2032)
  5. 6.2.1 Global Pyrazinamide Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Pyrazinamide Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Pyrazinamide Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Pyrazinamide Sales by Application (2021-2032)
  2. 7.1.1 Global Pyrazinamide Sales by Application (2021-2032) & (W Tons)
  3. 7.1.2 Global Pyrazinamide Sales Market Share by Application (2021-2032)
  4. 7.2 Global Pyrazinamide Revenue by Application (2021-2032)
  5. 7.2.1 Global Pyrazinamide Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Pyrazinamide Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Pyrazinamide Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Pyrazinamide Value Chain Analysis
  2. 8.1.1 Pyrazinamide Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Pyrazinamide Production Mode & Process
  5. 8.2 Pyrazinamide Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Pyrazinamide Distributors
  8. 8.2.3 Pyrazinamide Customers
9 Global Pyrazinamide Analyzing Market Dynamics
  1. 9.1 Pyrazinamide Industry Trends
  2. 9.2 Pyrazinamide Industry Drivers
  3. 9.3 Pyrazinamide Industry Opportunities and Challenges
  4. 9.4 Pyrazinamide Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.